You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Johnson and Johnson
Medtronic
Merck

Last Updated: April 6, 2020

DrugPatentWatch Database Preview

Plicamycin - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for plicamycin and what is the scope of freedom to operate?

Plicamycin is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for plicamycin.

Summary for plicamycin
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 11
Patent Applications: 7,239
DailyMed Link:plicamycin at DailyMed
Synonyms for plicamycin
18378-89-7
32318-EP2280012A2
32318-EP2281815A1
32318-EP2292615A1
32318-EP2301928A1
32318-EP2301933A1
32318-EP2305640A2
32318-EP2305671A1
32318-EP2311825A1
32318-EP2311827A1
97666-60-9
A-2371
Antibiotic LA 7017
Aurelic acid
Aureolic acid
Aurlelic acid
C12389
C52H76O24
CCRIS 5629
CHEBI:31856
CHEMBL257619
CS-0014261
D-threo-2-Pentulose, 5-deoxy-1-C-((2S,3S)-7-((2,6-dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-3-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1.fwdarw.3)-O-2,6-dideoxy-bet
D00468
DB06810
GTPL8394
HSDB 3238
HY-A0122
LS-91528
Mithracin
Mithracin (TN)
MITHRAMYCIN
mithramycin a
Mithramycine
Mithramycine [INN-French]
Mithramycinum
Mithramycinum [INN-Latin]
Mitramicina
Mitramicina [INN-Spanish]
Mitramycin
Mitramycine
Mitramycinum
NIJ123W41V
NSC 24559
PA 144
PA-144
Plicamicina
Plicamicina [INN-Spanish]
Plicamicina [Spanish]
Plicamycin (USP/INN)
Plicamycin [USAN:BAN:INN]
Plicamycin [USAN:USP:INN:BAN]
Plicamycine
Plicamycine [French]
Plicamycine [INN-French]
Plicamycinum
Plicamycinum [INN-Latin]
Plicamycinum [Latin]
SCHEMBL4517
SR-05000002335
SR-05000002335-2
SR-05000002335-3
UNII-NIJ123W41V

US Patents and Regulatory Information for plicamycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer MITHRACIN plicamycin INJECTABLE;INJECTION 050109-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Johnson and Johnson
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.